<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>61</Volume>
      <Issue>9</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>03</Month>
        <Day>16</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evaluation of the Effectiveness of Using Pulse Dose Radiofrequency for Treatment of Trigeminal Neuralgia</title>
    <FirstPage>578</FirstPage>
    <LastPage>581</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Saman</FirstName>
        <LastName>Sheikhhosseini</LastName>
        <affiliation locale="en_US">Department of Anesthesiology and Pain, Amir A&#x2019;lam Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nader Ali</FirstName>
        <LastName>Nazemian Yazdi</LastName>
        <affiliation locale="en_US">Department of Anesthesiology and Pain Medicine, Amir A&#x2019;lam Hospital, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>03</Month>
        <Day>16</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>03</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Trigeminal neuralgia has an incidence of 4-13 per 100000 people per year. The incidence of this disease increases in the elderly, and it is known to cause severe shock-like pain. Pharmacological therapy is the first-line treatment of trigeminal neuralgia. If pharmacological therapy fails, then different procedures are available. Pulse-dose radiofrequency is one such procedure. In this study, we evaluated Pulse dose radiofrequency's efficacy as a method in which pulse amplitude and width are considered essential variables. This research was conducted as a cross-sectional study on trigeminal neuralgia patients referred to the pain clinic of Amir A&#x2019;lam Hospital in 2020. Conservative therapy has failed; therefore, the clinician decided to use pulse dose radiofrequency to reduce their pain. Among the 29 patients registered during this period, 15 (51.8%) were women and 14 (48.3%) were men. The mean (&#xB1;SD) age of the patient was 57.07(&#xB1;14.26) years. The tow route was interrupted in 7 (24.1%) patients. A significant difference was observed between the pain scores before and after the operation (P&lt;0.001). Pulse-dose radiofrequency is a safe and effective therapy for treating trigeminal neuralgia and can be considered a new way to develop the pulse radiofrequency method.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/11022</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/11022/5843</pdf_url>
  </Article>
</Articles>
